Delivery Order SPE2DE24D0013-SPE2D626F90S1

Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $1,694 firm fixed-price delivery order (Contract No. XPRS-COV2-10) by the Defense Logistics Agency Medical Supply Chain on January 7, 2026. The delivery order, with an ultimate completion date of January 14, 2026, is issued under Cepheid's existing Indefinite Delivery Contract with the Veterans Health Administration VISN 17, valued at $6.7 million through December 28, 2029. The award carries no set-aside designation and is for diagnostic reagents and test kits, specifically XPRS-COV2-10 cartridges designed for the GeneXpert diagnostic platform to detect respiratory pathogens including COVID-19. Performance will occur at Cepheid's headquarters in Sunnyvale, California.

This delivery order exemplifies the Department of Veterans Affairs' reliance on Cepheid as a core federal supplier of molecular diagnostic capabilities. Cepheid maintains extensive procurement relationships across the VA system, including a larger single-award IDC with VISN 6 valued at $32.8 million through September 30, 2030, and has established itself as a primary federal supplier to multiple health agencies including the Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's diagnostic solutions support clinical laboratory operations and infectious disease testing requirements across the VA's distributed network of medical centers, with delivery orders historically ranging from approximately $41,000 to $970,000 under firm fixed-price structures.